These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36999800)

  • 41. [Expression and clinicopathological significance of
    Yang XG; Yang JW; Zhao PJ; Cheng W; Shi HB; Zhang B; Fu QC; Li Y
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2021 Apr; 33(2):148-153. PubMed ID: 34008361
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Prognostic value of lymph node ratio staging system in stage III( rectal cancer following 30 Gy/10 f preoperative radiotherapy].
    Wang L; Li Z; Li M; Peng Y; Gu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Oct; 17(10):990-6. PubMed ID: 25341906
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognosis of synchronous colorectal carcinoma compared to solitary colorectal carcinoma: a matched pair analysis.
    He W; Zheng C; Wang Y; Dan J; Zhu M; Wei M; Wang J; Wang Z
    Eur J Gastroenterol Hepatol; 2019 Dec; 31(12):1489-1495. PubMed ID: 31441800
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Examination of lymph nodes in resected colon segments with colorectal carcinoma].
    Dušek M; Chlumská A; Mukenšnabl P; Zámečník M
    Rozhl Chir; 2013 May; 92(5):250-4. PubMed ID: 23965128
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preoperative anemia and long-term survival in patients undergoing colorectal cancer surgery: a retrospective cohort study.
    Deng Y; Weng M; Zhang J
    World J Surg Oncol; 2023 Apr; 21(1):122. PubMed ID: 37013545
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The prognostic value of tumor budding in patients who had surgery for rectal cancer with and without neoadjuvant therapy.
    Şirin AH; Sökmen S; Ünlü SM; Ellidokuz H; Sarioğlu S
    Tech Coloproctol; 2019 Apr; 23(4):333-342. PubMed ID: 30900039
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Abdominoperineal excision following preoperative radiotherapy for rectal cancer: unfavorable prognosis even with negative circumferential resection margin.
    Wang L; Gu GL; Li ZW; Peng YF; Gu J
    World J Gastroenterol; 2014 Jul; 20(27):9138-45. PubMed ID: 25083087
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of preoperative thrombocytosis on the survival of patients with primary colorectal cancer.
    Sasaki K; Kawai K; Tsuno NH; Sunami E; Kitayama J
    World J Surg; 2012 Jan; 36(1):192-200. PubMed ID: 22045447
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Apical Lymph Nodes in the Distant Metastases and Prognosis of Patients with Stage III Colorectal Cancer with Adequate Lymph Node Retrieval Following FOLFOX Adjuvant Chemotherapy.
    Tsai HL; Chen YT; Yeh YS; Huang CW; Ma CJ; Wang JY
    Pathol Oncol Res; 2019 Jul; 25(3):905-913. PubMed ID: 29299827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
    Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
    [No Abstract]   [Full Text] [Related]  

  • 51. [Analysis of risk factors for bone metastasis after radical resection of colorectal cancer within 5 years].
    Li A; Tan Z; Fu C; Wang H; Yuan J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):58-61. PubMed ID: 28105621
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The significance of tumor budding in T1 colorectal carcinoma: the most reliable predictor of lymph node metastasis especially in endoscopically resected T1 colorectal carcinoma.
    Lee SJ; Kim A; Kim YK; Park WY; Kim HS; Jo HJ; Oh N; Song GA; Park DY
    Hum Pathol; 2018 Aug; 78():8-17. PubMed ID: 29447923
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinicopathological and prognostic features of young onset patients with middle-low rectal cancer received neoadjuvant chemoradiotherapy].
    Zhang QQ; Wu YL; Li DD; Shen SH; Fang H; Zhu YL; Zhang HZ
    Zhonghua Zhong Liu Za Zhi; 2021 May; 43(5):574-580. PubMed ID: 34034478
    [No Abstract]   [Full Text] [Related]  

  • 54. [Surgical treatment and prognosis of Borrmann type IIII( gastric cancer involving the whole stomach].
    Dong R; Zhang Z; Zhou Y; Hua Y; Guo J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):185-189. PubMed ID: 29492918
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pulmonary nodules and metastases in colorectal cancer.
    Nordholm-Carstensen A
    Dan Med J; 2016 Jan; 63(1):B5190. PubMed ID: 26726908
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term outcomes after treatment for T1 colorectal carcinoma: a multicenter retrospective cohort study of Hiroshima GI Endoscopy Research Group.
    Tamaru Y; Oka S; Tanaka S; Nagata S; Hiraga Y; Kuwai T; Furudoi A; Tamura T; Kunihiro M; Okanobu H; Nakadoi K; Kanao H; Higashiyama M; Arihiro K; Kuraoka K; Shimamoto F; Chayama K
    J Gastroenterol; 2017 Nov; 52(11):1169-1179. PubMed ID: 28194526
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinicopathological Factors Associated with Recurrence and Prognosis after R0 Resection for Stage IV Colorectal Cancer with Peritoneal Metastasis.
    Sato H; Kotake K; Sugihara K; Takahashi H; Maeda K; Uyama I;
    Dig Surg; 2016; 33(5):382-91. PubMed ID: 27119565
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic factors predicting survival in incurable stage IV colorectal cancer patients who underwent palliative primary tumor resection. Retrospective cohort study.
    Kim MS; Park EJ; Kang J; Min BS; Lee KY; Kim NK; Baik SH
    Int J Surg; 2018 Jan; 49():10-15. PubMed ID: 29198632
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The association of mucinous histology with clinicopathological characteristics and long-term oncological outcome in patients with colorectal cancer.
    Tümay V; Guner OS
    Ann Ital Chir; 2020; 91():639-648. PubMed ID: 32990276
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon 2 non-mutant) metastatic colorectal cancer: a nationwide cohort study.
    Chen KH; Shao YY; Chen HM; Lin YL; Lin ZZ; Lai MS; Cheng AL; Yeh KH
    BMC Cancer; 2016 May; 16():327. PubMed ID: 27221731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.